Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Neuropace Inc
NASDAQ:NPCE
Neuropace Inc
NASDAQ:NPCE
Price:
12.67
USD
2.26%
Market Cap:
$431.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
Samsung SDI Co Ltd
F:XSDG
|
KR |
|
T
|
Texas Roadhouse Inc
SWB:ROW
|
US |
|
Wellnex Life Ltd
F:22W0
|
AU |
|
P
|
Prabos Plus as
PSE:PRAB
|
CZ |
|
F
|
Fuxing China Group Ltd
SGX:AWK
|
CN |
|
I
|
IBKS No.24 Special Purpose Acquisition Co
KOSDAQ:469480
|
KR |
|
First Community Bankshares Inc
NASDAQ:FCBC
|
US |
|
P
|
Premium Snacks Nordic AB
F:N3K
|
SE |
|
Centrale del Latte d'Italia SpA
MIL:CLI
|
IT |
|
G
|
George Weston Ltd
F:WX5
|
CA |
|
A
|
Australian Vanadium Ltd
F:JT71
|
AU |
Wall St Price Targets
NPCE Price Forecast
Based on 12 analysts
Based on 12 analysts
+61% Upside
from
$12.67
today
Neuropace Inc (NPCE)’s 12-month stock price forecast through October 2027 has a consensus target of $20.4, implying 61% upside. The forecast is based on price targets from 12 Wall Street analysts.
NPCE Analyst Rating
Based on 10 analysts
Based on 10 analysts
Analysts rate NPCE Strong buy, with 10 of 10 recommending Buy or Strong buy.
Neuropace Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NPCE's stock price target?
Price Target
20.4
USD
20.4
USD
According to Wall Street analysts, the average 1-year price target for NPCE is 20.4 USD with a low forecast of 18.18 USD and a high forecast of 23.1 USD.
What is the Revenue forecast for Neuropace Inc?
Projected CAGR
13%
13%
Over the last 5 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 5 years is 13%.
What is the Gross Profit forecast for Neuropace Inc?
Projected CAGR
18%
18%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 3 years is 18%.